Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Superior Colliculus Activity in Parkinson Disease: a Potential Marker?

View source ↗

Summary

A completed clinical trial investigates whether superior colliculus activity could serve as a biomarker for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Parkinson's Disease | Status: COMPLETED